Three independent discounted-cash-flow-style models value USANA Health Sciences Inc every trading day. 3 of 3 currently price USNA above its market price.
| Free Cash Flow model | $52.96 |
| Excess Profit model | $30.20 |
| Residual Earnings model | $25.59 |
| Dividend Discount model | — |
| Piotroski F-Score | 6 / 9 |
| Return on invested capital | +9.5% |
| Net debt / EBITDA | 0.3× |
| Gross margin | +81.1% |
| Revenue CAGR | -9.0% |
| Cash conversion | 1.5× |
| Dividend yield | — |
| Buyback yield | +0.8% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open USNA in StockKitty